Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000000309DOI Listing

Publication Analysis

Top Keywords

option menopausal
4
menopausal vasomotor
4
vasomotor symptoms
4
symptoms negative
4
negative impact
4
impact weight
4
weight sexual
4
sexual function
4
option
1
vasomotor
1

Similar Publications

Pelvic organ prolapse (POP) affects quality of life of many women. This paper aims to identify the experience of postmenopausal women in treatment decision-making process about POP before gynecological surgery. The characteristics of twelve postmenopausal women with stage II, III and IV POP, such as age, body mass index (BMI), physical exercise, education, parity, abortions, comorbidities, previous surgical interventions, and smoker/nonsmoker were evaluated.

View Article and Find Full Text PDF

Background Female sexual dysfunction (FSD) affects a significant portion of the female population, negatively impacting quality of life. New therapeutic approaches, such as the combination of laser therapy and platelet-rich plasma (PRP), are being explored as potential treatments to enhance sexual function in affected women. Methods This original study involved 23 women aged 37 to 72, all diagnosed with varying degrees of FSD (mild, moderate, severe).

View Article and Find Full Text PDF

Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) and vasomotor symptoms (VMS) are associated with increased cardiovascular disease risk. Although visceral adiposity has been linked to MASLD and VMS independently, this study aimed to evaluate associations between the two in midlife women.

Methods: A cross-sectional study of women aged 45-60 years receiving primary care at one of four sites was conducted from March 1 through June 30, 2021.

View Article and Find Full Text PDF

Background: Genitourinary syndrome of menopause (GSM) is a condition affecting many postmenopausal women. Among the available treatments, the vaginal natural oxygenation device (VNOD) is a new promising option.

Aim: To evaluate the safety and the effectiveness of vaginal high concentration (HC) oxygen (O) and hyaluronic acid (HA) in postmenopausal women with vaginal atrophy (VA).

View Article and Find Full Text PDF
Article Synopsis
  • - This study explored whether there are health disparities in the prescription and use of menopause hormone therapy among perimenopausal and early postmenopausal women in the USA, by reviewing observational studies from 1940 until October 2023.
  • - Researchers found 16 different health disparities related to hormone therapy, noting significant differences based on ethnicity, education, medical conditions, and practitioner specialization.
  • - The findings indicate long-standing disparities in hormone therapy access and usage, highlighting the need for improved education for healthcare providers to better serve underserved populations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!